Millions of people with diabetes and other serious chronic conditions around the world depend on Novo Nordisk to produce life-saving medicines. We believe the best way we can continue helping them, and the increasing number of people who will need treatment in the future, is by taking responsibility for the impact our business has on people, communities and the environment and striving to make a positive contribution to prosperity and well-being.
We build our company on the conviction that to be a sustainable business we must balance three bottom lines – financial, social and environmental.
We call this the Triple Bottom Line (TBL) business principle. It sets out how we manage our business with an ambition to be sustainable and account for performance in three dimensions.